TCRX is trading at $0.89 (8.6% down) in after-hours trading as the stock pulls back from a sharp 11.1% intraday rally earlier on June 26, 2026.

  • No fresh earnings, M&A, clinical, or financing announcements have been released to explain the recent price fluctuations.
  • The downward move appears to be normal market volatility and profit-taking following the stock's recent gains rather than a reaction to new company-specific developments.